These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 9796840

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of converting enzyme inhibitors on coronary flow and myocardial ischemia.
    van Gilst WH, Tio RA, van Wijngaarden J, de Graeff PA, Wesseling H.
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S134-9. PubMed ID: 1381790
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Coronary endothelial vasodilator dysfunction: clinical relevance and therapeutic implications.
    Zeiher AM, Schächinger V.
    Z Kardiol; 1994; 83 Suppl 4():7-14. PubMed ID: 7856284
    [Abstract] [Full Text] [Related]

  • 5. [Coronary endothelial dysfunction in hypertension].
    Antony I, Nitenberg A.
    Arch Mal Coeur Vaiss; 1997 Nov; 90 Spec No 6():21-7. PubMed ID: 9515110
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Significance of angiotensin converting enzyme (ACE) in coronary circulation].
    Mauer Díaz K, Exaire Murad JE, Escalante Acosta BA.
    Arch Cardiol Mex; 2001 Nov; 71(4):278-85. PubMed ID: 11806030
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G.
    Eur J Pharmacol; 2005 Jun 15; 516(3):253-9. PubMed ID: 15963975
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of the slow pressor effect of angiotensin II contributes to the antihypertensive effect of angiotensin-converting enzyme inhibitors in renovascular hypertension.
    Melaragno MG, Fink GD.
    J Pharmacol Exp Ther; 1996 Jul 15; 278(1):297-303. PubMed ID: 8764363
    [Abstract] [Full Text] [Related]

  • 11. Effect of acute hypertension in the coronary circulation: role of mechanical factors and oxygen radicals.
    De Bruyn VH, Nuno DW, Cappelli-Bigazzi M, Dole WP, Lamping KG.
    J Hypertens; 1994 Feb 15; 12(2):163-72. PubMed ID: 8021468
    [Abstract] [Full Text] [Related]

  • 12. [Restoration of normal coronary vasomotricity after intravenous infusion of angiotensin converting-enzyme inhibitor (perindoprilat) in hypertensive patients].
    Antony I, Lerebours G, Nitenberg A.
    Arch Mal Coeur Vaiss; 1995 Aug 15; 88(8):1125-8. PubMed ID: 8572858
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors.
    Goto K, Fujii K, Kansui Y, Iida M.
    Clin Exp Pharmacol Physiol; 2004 Sep 15; 31(9):650-5. PubMed ID: 15479174
    [Abstract] [Full Text] [Related]

  • 15. Acute effects of ACE inhibition on coronary endothelial dysfunction.
    Nickenig G, Stäblein A, Wassmann S, Wyen C, Müller C, Böhm M.
    J Renin Angiotensin Aldosterone Syst; 2000 Dec 15; 1(4):361-4. PubMed ID: 11967824
    [Abstract] [Full Text] [Related]

  • 16. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
    Guidi E, Hollenberg NK.
    J Hypertens Suppl; 1986 Dec 15; 4(6):S480-2. PubMed ID: 11538668
    [Abstract] [Full Text] [Related]

  • 17. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats.
    Resende AC, Pimentel AM, de Moura RS.
    Clin Exp Pharmacol Physiol; 2004 Nov 15; 31(11):756-61. PubMed ID: 15566389
    [Abstract] [Full Text] [Related]

  • 18. [Coronary microangiopathy in hypertensive heart disease: pathogenesis, diagnosis and therapy].
    Motz W, Scheler S, Strauer BE.
    Herz; 1995 Dec 15; 20(6):355-64. PubMed ID: 8582695
    [Abstract] [Full Text] [Related]

  • 19. Restoration of flow-dependent coronary dilation by ACE inhibition improves papaverine-induced maximal coronary blood flow in hypertensive patients: demonstration that large epicardial coronary arteries are more than conductance vessels.
    Antony I, Chemla D, Lerebours G, Nitenberg A.
    J Cardiovasc Pharmacol; 2000 Nov 15; 36(5):570-6. PubMed ID: 11065216
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.